The Featherstone column of BRW magazine asked Sebastian Evans of NAOS Asset Management for his best three small biotech investments. He lists TIS, PAB and Phylogica.
BRW weekly 15-21 Sept edition pages 54-55, Value in Biotechs.
He says the X factor = Rapid revenue growth from 2013.
Add to My Watchlist
What is My Watchlist?